Rhoen Klinikum AG RHK
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €12.60
- Day Range
- €12.40–12.50
- 52-Week Range
- €9.50–14.00
- Bid/Ask
- €12.40 / €12.50
- Market Cap
- €830.04 Mil
- Volume/Avg
- 2,160 / 1,964
Key Statistics
- Price/Earnings (Normalized)
- 12.04
- Price/Sales
- 0.56
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Rhoen Klinikum AG provides medical care focused in five key areas: cardiovascular medicine, neuromedicine, oncology, pulmonary diseases, and orthopedic and trauma surgery. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on an outpatient basis. Rhoen Klinikum generates the entirety of its revenue in Germany, with the Bavaria and Hesse regions contributing the largest proportions of revenue.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Stock Style Box
- Small Core
- Total Number of Employees
- 18,282
Comparables
Valuation
Metric
|
RHK
|
MD
|
AKT
|
---|---|---|---|
Price/Earnings (Normalized) | 12.04 | 10.28 | — |
Price/Book Value | 0.66 | 1.47 | — |
Price/Sales | 0.56 | 0.50 | — |
Price/Cash Flow | 8.66 | 8.04 | — |
Price/Earnings
RHK
MD
AKT
Financial Strength
Metric
|
RHK
|
MD
|
AKT
|
---|---|---|---|
Quick Ratio | 2.18 | 1.31 | 0.54 |
Current Ratio | 2.34 | 1.38 | 0.60 |
Interest Coverage | 14.02 | −5.48 | 11.08 |
Quick Ratio
RHK
MD
AKT
Profitability
Metric
|
RHK
|
MD
|
AKT
|
---|---|---|---|
Return on Assets (Normalized) | 2.62% | 4.44% | 5.43% |
Return on Equity (Normalized) | 3.72% | 11.31% | 14.42% |
Return on Invested Capital (Normalized) | 2.90% | 8.59% | 10.12% |
Return on Assets
RHK
MD
AKT
Medical Care Facilities Industry Comparables
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|---|
HCA Healthcare Inc
HCA
| Dnpsfjs | Cxncdcd | $101.3 Bil | |||
Fresenius SE & Co KGaA
FSNUF
| — | Xncqvwj | $21.1 Bil | |||
Fresenius SE & Co KGaA ADR
FSNUY
| — | Txyhgv | $21.1 Bil | |||
Tenet Healthcare Corp
THC
| Njplxjm | Mnqbj | $15.0 Bil | |||
Universal Health Services Inc Class B
UHS
| — | Qdhnd | $14.4 Bil | |||
Bangkok Dusit Medical Services PCL ADR
BDUUY
| — | Vhqg | $14.2 Bil | |||
DaVita Inc
DVA
| Jkvgzdkn | Qzbcnyy | $13.3 Bil | |||
Fresenius Medical Care AG
FMCQF
| — | Bwtvrq | $12.2 Bil | |||
Fresenius Medical Care AG ADR
FMS
| Zkb | Cpgbz | $12.2 Bil | |||
Encompass Health Corp
EHC
| — | Wbjqnrq | $9.5 Bil |